GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Medpace Holdings Inc (MEX:MEDP) » Definitions » Shiller PE Ratio

Medpace Holdings (MEX:MEDP) Shiller PE Ratio : 51.48 (As of Apr. 26, 2025)


View and export this data going back to 2019. Start your Free Trial

What is Medpace Holdings Shiller PE Ratio?

As of today (2025-04-26), Medpace Holdings's current share price is MXN5869.75. Medpace Holdings's E10 for the quarter that ended in Mar. 2025 was MXN114.03. Medpace Holdings's Shiller PE Ratio for today is 51.48.

The historical rank and industry rank for Medpace Holdings's Shiller PE Ratio or its related term are showing as below:

MEX:MEDP' s Shiller PE Ratio Range Over the Past 10 Years
Min: 55.86   Med: 75.9   Max: 107.52
Current: 57.38

During the past years, Medpace Holdings's highest Shiller PE Ratio was 107.52. The lowest was 55.86. And the median was 75.90.

MEX:MEDP's Shiller PE Ratio is ranked worse than
82.28% of 79 companies
in the Medical Diagnostics & Research industry
Industry Median: 25.68 vs MEX:MEDP: 57.38

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Medpace Holdings's adjusted earnings per share data for the three months ended in Mar. 2025 was MXN75.082. Add all the adjusted EPS for the past 10 years together and divide 10 will get our E10, which is MXN114.03 for the trailing ten years ended in Mar. 2025.

Shiller PE for Stocks: The True Measure of Stock Valuation


Medpace Holdings Shiller PE Ratio Historical Data

The historical data trend for Medpace Holdings's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Medpace Holdings Shiller PE Ratio Chart

Medpace Holdings Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Shiller PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - 70.53

Medpace Holdings Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Shiller PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 99.89 75.00 70.53 59.27

Competitive Comparison of Medpace Holdings's Shiller PE Ratio

For the Diagnostics & Research subindustry, Medpace Holdings's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Medpace Holdings's Shiller PE Ratio Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Medpace Holdings's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Medpace Holdings's Shiller PE Ratio falls into.


;
;

Medpace Holdings Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Medpace Holdings's Shiller PE Ratio for today is calculated as

Shiller PE Ratio=Share Price/ E10
=5869.75/114.03
=51.48

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Medpace Holdings's E10 for the quarter that ended in Mar. 2025 is calculated as:

For example, Medpace Holdings's adjusted earnings per share data for the three months ended in Mar. 2025 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Mar. 2025 (Change)*Current CPI (Mar. 2025)
=75.082/134.9266*134.9266
=75.082

Current CPI (Mar. 2025) = 134.9266.

Medpace Holdings Quarterly Data

Earnings per Share (Diluted) CPI Adj_EPS
201506 0.038 100.684 0.051
201509 -0.057 100.392 -0.077
201512 -3.721 99.792 -5.031
201603 1.498 100.470 2.012
201606 2.315 101.688 3.072
201609 2.514 101.861 3.330
201612 -0.011 101.863 -0.015
201703 3.766 102.862 4.940
201706 4.157 103.349 5.427
201709 4.537 104.136 5.879
201712 5.892 104.011 7.643
201803 7.267 105.290 9.313
201806 8.842 106.317 11.221
201809 9.727 106.507 12.323
201812 11.977 105.998 15.246
201903 9.893 107.251 12.446
201906 14.022 108.070 17.507
201909 12.437 108.329 15.491
201912 14.711 108.420 18.308
202003 17.820 108.902 22.079
202006 14.773 108.767 18.326
202009 24.079 109.815 29.585
202012 26.854 109.897 32.970
202103 23.303 111.754 28.135
202106 21.100 114.631 24.836
202109 26.525 115.734 30.924
202112 27.078 117.630 31.060
202203 33.650 121.301 37.430
202206 29.372 125.017 31.700
202209 41.236 125.227 44.430
202212 41.332 125.222 44.535
202303 40.917 127.348 43.352
202306 33.088 128.729 34.681
202309 38.670 129.860 40.179
202312 41.757 129.419 43.534
202403 53.108 131.776 54.378
202406 50.380 132.554 51.282
202409 59.268 133.029 60.113
202412 76.540 133.157 77.557
202503 75.082 134.927 75.082

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Medpace Holdings  (MEX:MEDP) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


Medpace Holdings Shiller PE Ratio Related Terms

Thank you for viewing the detailed overview of Medpace Holdings's Shiller PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Medpace Holdings Business Description

Traded in Other Exchanges
Address
5375 Medpace Way, Cincinnati, OH, USA, 45227
Medpace is a late-stage contract research organization that provides full-service drug-development and clinical trial services to small and midsize biotechnology, pharmaceutical, and medical-device firms. It also offers ancillary services such as bioanalytical laboratory services and imaging capabilities. The company was founded over 30 years ago and has over 5,400 employees across 40 countries. Medpace is headquartered in Cincinnati and its operations are principally based in the us, but it also operates in Europe, Asia, South America, Africa, and Australia. Cinven, a global private equity firm, acquired Medpace for $915 million in 2014 and exited its investment in 2018.